Committee on Herbal Medicinal Products

Acronym for "Committee on Herbal Medicinal Products" (Committee for Herbal Medicinal Products of the European Medicines Agency). The HMPC was established at the EuropeanMedicines Agency (EMA, London) in 2004 on the basis of a European regulation. The HMPC is one of seven scientific committees of the EMA and underlines the importance that the European Parliament attaches to the harmonization of the evaluation of herbal medicinal products and their availability in the European Union.

The committee consists of one expert representative appointed by each member state (employees of the national authorities or experts from universities) and five co-opted members who represent specific subject areas. Currently, these are, for example, general medicine, pediatrics, pharmacology and toxicology.

The HMPC and its scientific working parties are involved in the preparation of plant monographs. One of the HMPC's main tasks is to harmonize the regulations for the use of phytotherapeutics at European level.

The main tasks of the HPMC include the preparation of Community herbal monographs, a task for which Commission E was responsible in the Federal Republic of Germany until 1994. The HMPC monographs thus represent the new European regulatory standard (valid for the member states of the European Union). Not only the summaries are published in the form of monographs, but also assessment reports and reference lists.

It is possible to obtain information on the current state of scientific knowledge at any time. The approved monographs are an important decision-making basis for the national regulatory authorities in all European countries.

For a long time, the Commission E monographs were the official standard in Germany. This was recognized and respected worldwide. The Commission E monographs have not been updated since 1994. This means that the HMPC is effectively the successor to Commission E.